Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective studyResearch in context

Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective studyResearch in context

Summary: Background: Abnormal liver function was frequently observed in nonalcoholic fatty liver disease (NAFLD) patients infected with SARS-CoV-2. Our aim was to explore the effect of SARS-CoV-2 inactivated vaccines on liver function abnormality among NAFLD patients with COVID-19. Methods: The mul...

Full description

Bibliographic Details
Main Authors: Zhixue Chen, Wenqing Tang, Nana Feng, Minzhi Lv, Fansheng Meng, Huibin Wu, Yitong Zhao, Huajie Xu, Yuxin Dai, Jindan Xue, Jingya Wang, Anjun Xu, Beilin Zhang, Dejie Chu, Yuqin Li, Dejun Wu, Ling Dong, Si Zhang, Ruyi Xue
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EBioMedicine
Subjects:
COVID-19
Nonalcoholic fatty liver disease
Inactivated SARS-CoV-2 vaccine
Liver function abnormality
Direct bilirubin
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396423004784

Internet

http://www.sciencedirect.com/science/article/pii/S2352396423004784

Similar Items